A Trial of Thalidomide, Celecoxib, Etoposide and Cyclophosphamide in Patients With Relapsed or Progressive Cancer
Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
This study will use a combination of four oral drugs (thalidomide, cyclophosphamide,
etoposide and celecoxib) to treat patients with relapsed or progressive cancer. These drugs
are expected to target the blood vessels that supply the tumors with what they need to grow.